News from the HMI

NEW YORK, May 01, 2019 – Human Microbiology Institute, today announced a poster presentation “A New Developmental Model of Type 1 Diabetes—An Association between Autoimmunity, the Dynamics of Gut Amyloid-Producing E. Coli, and Their Phages” at the The American Diabetes Association’s 79th Scientific Sessions  being held on June 7-11, San Francisco. The presentation includes the first microbiome-based discovery for the role of microbiome in triggering Type 1 Diabetes autoimmunity.

Bacteriophages are Potential New Human Pathogens

Human Microbiology Institute Research the First to Demonstrate that Amyloid-producing Bacteria and Bacteriophages Can Trigger Type 1 Diabetes

Research was presented at the 5th Annual Translational Microbiome Conference 2019

Boston, MA, April 17, 2019 — Human Microbiology Institute (HMI), a not-for-profit scientific research organization, today presented data that demonstrate for the first time how microbiome can trigger type 1 diabetes. The study, conducted by Drs. V. and G. Tetz, was presented by Dr. G. Tetz in an oral session at 5th Annual Translational Microbiome Conference , April 16–18, 2019, in Boston.

Type 1 Diabetes: Primary Prevention Therapeutic Programs and First Pre-Autoantibody Biomarker Based on Association Between Autoimmunity and Dynamics of Amyloid-Producing E.coli

Human Microbiology Institute research the first propose the concept of novel cause of Type 1 Diabetes development. In this study we discovered the effect of certain  gut bacteria and bacteriophages on triggering autoimmunity and  seroconversion in HLA-susceptible children.

 Research Will Be Presented at 5^th Annual Translational Microbiome Conference (https://www.microbiomeconference.com/ )

An interview with Dr. George Tetz, MD, Ph.D., discussing the discovery of the role of bacteriophages in nneurodegeneration is available online here

Our presentation “Parkinson’s disease and bacteriophages as its overlooked contributors” has been selected as a Neuroscience 2018 Hot Topic, which SfN distributes to the media. Limited copies of the Hot Topics book are printed exclusively for the media.

HMI Discovers Previously Unknown Prion-Like Viral Proteins, Opening New Targets for Antiviral Drugs

Bacteriophages: Are they an overlooked driver of Parkinson’s disease?

Bacteriophages: Are They an Overlooked Driver of Parkinson’s Disease?

Human Microbiology Institute research the first propose the concept of bacteriophages as human pathogens. In this study we discovered the effect of certain  bacteriophages on the microbiota of patients with Parkinson’s disease  (PD) that might contribute to the onset of this pathology

 Research Will Be Presented at American Society for Microbiology (ASM) Microbe 2018